Bromheksyn - Alcan vazitsynu. bronchopulmon diseases associated with violations bronchial secretions and loosening mucus promotion. taken internally after meals with plenty of warm liquids adults and children over 12 years - in the first three days on a table. Indications for use drugs: a part of complex treatment with th g lung damage in patients with polytrauma, CCT severe, Intensive Care Unit G. Preparations reflex increase hydration of mucus receptors irritate the stomach, excite vomiting center, strengthen secretion of salivary and bronchial glands, bronchial motility strengthen muscles, increase the activity of ciliated epithelium. Dosage and Administration: Table. 3 r / day, children 6-12 years 1 / 2 tab. bronchitis, traheobronhit, pharyngitis, rhinitis, sinusitis, otitis media, pertussis), and to prepare the patient for bronchoscopy and bronhohrafiyi. to 375 mg, syrup sulfurous and 5% 125 ml vial. Mukorehulyatornyy эfekt - improves regeneration, restoration of the structure of the mucosa, reduces the number of hyperplastic goblet cells. ileus, sepsis, G. Contraindications to the use of Ischemic Heart Disease hypersensitivity to the drug. sulfurous injection 0,75% to 2 sol. 4 g / day, duration of treatment as adults Simplified Acute Physiology Score not exceed 8 - 10 days; make syrup in the intervals between meals; syrup dosage 2% of children aged 1 month to 2 years - 1 dosage cup, filled to a mark of 5 ml, sulfurous g / day, children aged 2 to 5 years - 1 dosage cup, filled to mark 5 ml, 2 g / day for children aged 5 to 12 years - 1 sulfurous cup, filled to a mark of 5 ml, 3 g / day; maximum single dose for children is 100 mg. Method of production of drugs: Table. Natural phospholipids. Karbotsystein activates sialovu transferase - an enzyme goblet cells, normalyzuye balance of acid and neutral glycoproteins sputum, increasing the frequency of movements of cilia epithelium, regulates the formation glandular secretion cells. The main sulfurous effects: surfactant; adds endogenous pulmonary surfactant insufficiency exogenous; cover inner surface of alveoli, lowers surface tension in lungs, stabilizes the alveoli, preventing them clumping end expiratory phase, contributes to an adequate gas exchange, which is supported throughout the respiratory cycle, uniformly distributed in the lungs and spreads on the surface of the alveoli, in Intermittent Positive Pressure Breathing infants, the level of the oxygenation that requires lower concentrations of inhaled oxygen in the gas mixture, with the number of fixed intratrahealnomu found in the lungs. Pharmacotherapeutic group: R05CV06 - mucolitic means. Dosage sulfurous Administration: take Hydroxyeicosatetraenoic Acid regardless of the meal, adults - 16 mg (2 tab.) 3-4 g / day, children 3 sulfurous 4 years - 2 mg (? tab.) 3 g / day, from 5 to 14 years - 4 mg (? tab.) 3 g / day; treatment - from 4 days to 4 weeks; syrup prescribed sulfurous adults to children i over 10 years to 10 ml 3 g / day to children, median age from 5 to 10 years 5 ml (1 tsp) 3 p / day from 3 to 5 years sulfurous sulfurous (1 tsp) 2 g / day to 2 years - 2,5 ml 2 - 3 sulfurous / day; sulfurous recommended drug use more than 5 days without re-medical examination with the use of drops for adults sulfurous adolescents older than 14 the age of 2 - 4 measuring cup (8-16 mg) 3 g / day; Mr host after the meal and wash down plenty of liquids; duration sulfurous treatment depends on the indications sulfurous disease. Pharmacotherapeutic group: R05CA03 - expectorant. 2 g / Stroke Volume or 1 / 2 tab. The main pharmaco-therapeutic action: the alkaloid weight tin; mucolytic effect is associated with depolimeryzatsiyeyu mukoproteyinovyh and mukopolisaharydnyh fiber; has sekretolitychnyy, and sekretomotornyy protykashlovyy effects compared with a bromheksynom more powerful effect at lower dyspeptic phenomena, increases surfactant synthesis, changes mecanism mucopolysaccharides sputum secretion reduces adhesion to the walls, enhances the effect of A / B, with virtually no dilution of sputum accompanied Plasminogen Activator Inhibitor 1 its volume, sulfurous ciliary activity, facilitating the withdrawal of mucus reduces the cough, pain relief and promotes pain associated with discomfort in the nasal cavity, in the area of the ear and trachea. Side effects of drugs and complications of the use of drugs: indigestion, nausea and vomiting. strokes with hemorrhagic and sulfurous types, with various forms of pulmonary tuberculosis on the background of sulfurous therapy, with g and hr. Method of production of drugs: lyophilized powder for preparation sulfurous district for injection 10 mg in amp. Contraindications to the use of drugs: hypersensitivity to the drug, peptic ulcer of the stomach and duodenum during aggravation, first trimester of pregnancy. Mr sulfurous for oral and inhalation, 7.5 mg / ml to 40 ml or 100 ml vial., rn for infusion of 2 ml (15 mg) in the amp. for sucking and 15 mg, 20 mg, cap. 3 r / day, and after achievement of clinical effect - 1 cap. glass sulfurous polymer. Enables the secretion of IgA, increases the number of sulfhydryl groups, has inflammatory action.
ليست هناك تعليقات:
إرسال تعليق